Concern prevails in Cyprus after the death of the 39-year-old British woman after a thromboembolic event.
The 39-year-old was recently hospitalized at the Nicosia General Hospital, while she was vaccinated with the AstraZeneca drug on May 6 and it is being investigated whether it is related to the thrombosis she suffered.
Speaking to SigmaLive, Dr. Marios Antoniadis, Hematologist and Head of the Hemophilia-Thrombophilia Unit of the Nicosia General Hospital, stated that the frequency of the vaccine induced immune thrombotic thrombocytopenia syndrome - VITT (ie of immune origin thrombotic thrombosis is 6- appeared reassuring.
As he noted, this syndrome is more common in women under 50 years of age.
Asked if anyone with a history of thrombosis should not be vaccinated, Mr. Antoniadis said there was no reason not to be vaccinated.
As for when the symptoms of the syndrome may appear, he said that it is usually 4-30 days after the vaccination.
If the thrombosis is in the brain, the patient will experience prolonged headache, neurological symptoms, and severe anxiety.
If it is in the abdomen, he said, there will be unusual pain in the abdomen.
In case of thrombosis in the lungs, the patient will feel severe pain in the chest and if it is in the extremities, then they will swell.
At the same time, he noted, bleeding may coexist with symptoms of low platelets with obvious bruising on the skin.
He stressed that it is extremely rare for a patient to have a thrombosis and not realize that something is wrong.
Mr. Antoniadis stressed that one does not need to take aspirin before or after the vaccine, as well as anticoagulants.
In addition, he noted that one does not need to have blood tests to check for thrombophilia before being vaccinated.
Asked to comment if someone has a thrombosis after being vaccinated with the first dose and has been treated, he should take the second dose with another vaccine, he replied that he should be given the same vaccine.
Source: Sigmalive
